Yassir Boulaamane

6PUBLICATIONS
6CO-AUTHORS
Toxicology (incl. clinical toxicology)Biomolecular modelling and designCharacterisation of biological macromoleculesMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2026
QSAR-Guided Virtual Screening and Molecular Dynamics Reveal Olaparib as a Repurposing Lead Against α-Synuclein Aggregation.

|Aug 13, 2026
FDA-Approved Drug Repurposing as p53 Mutants Rescue Candidates Using Structure-Based Virtual Screening and Molecular Simulations.

|Jul 28, 2026
Repurposing FDA-Approved Drugs as Nav1.7 Channel Modulators: An Integrated Structure-Based Virtual Screening and Molecular Dynamics Study.

|Jun 12, 2026
ARumenamides as Multitarget Ion Channel Modulators: Insights from Fenestration-Focused Docking, ADMET Profiling, and Molecular Dynamics.

|Sep 16, 2022
In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA2AR antagonists for the treatment of Parkinson's disease.

Yassir Boulaamane, Mahmoud A A Ibrahim, Mohammed Reda Britel

|Feb 16, 2022
Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors.

Yassir Boulaamane, Iqrar Ahmad, Harun Patel

Pageof 1

Frequent Collaborators

2 joint publications

Mohammed Reda Britel

2 joint publications

Amal Maurady

1 joint publications

Iqrar Ahmad

1 joint publications

Harun Patel